NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
Want to see NAMS full AI Analyst Report?
Technical Sentiment
Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
NewAmsterdam Pharma Company’s (NAMS) Moving Averages Convergence Divergence (MACD) indicator is 0.78, suggesting NewAmsterdam Pharma Company is a Sell.
NewAmsterdam Pharma Company’s (NAMS) 20-Day exponential moving average is 33.25, while NewAmsterdam Pharma Company’s (NAMS) share price is $34.68, making it a Buy.
NewAmsterdam Pharma Company’s (NAMS) 50-Day exponential moving average is 32.88, while NewAmsterdam Pharma Company’s (NAMS) share price is $34.68, making it a Buy.
NewAmsterdam Pharma Company (NAMS) Pivot Points
Classic
31.16
32.02
32.61
33.46
34.05
34.91
35.50
Fibonacci
32.02
32.57
32.91
33.46
34.01
34.35
34.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
NewAmsterdam Pharma Company (NAMS) Moving Averages
MA5
34.52Buy
34.27Buy
MA10
34.44Buy
33.98Buy
MA20
32.64Buy
33.25Buy
MA50
32.75Buy
32.88Buy
MA100
33.83Buy
32.68Buy
MA200
31.21Buy
29.67Buy
NewAmsterdam Pharma Company’s (NAMS) 10-Day exponential moving average is 33.98, while NewAmsterdam Pharma Company’s (NAMS) share price is $34.68, making it a Buy.
NewAmsterdam Pharma Company’s (NAMS) 100-Day exponential moving average is 32.68, while NewAmsterdam Pharma Company’s (NAMS) share price is $34.68, making it a Buy.
NewAmsterdam Pharma Company’s (NAMS) stock price is $34.68 and NewAmsterdam Pharma Company’s (NAMS) 50-day simple moving average is 32.75, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $34.68 and NewAmsterdam Pharma Company’s (NAMS) 100-day simple moving average is 33.83, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $34.68 and NewAmsterdam Pharma Company’s (NAMS) 200-day simple moving average is 31.21, creating a Buy signal.
NewAmsterdam Pharma Company (NAMS) Technical Indicators
RSI (14)
56.92
Neutral
STOCH (9,6)
36.99
Neutral
STOCHRSI (14)
63.86
Neutral
MACD (12,26)
0.78
Sell
ADX (14)
25.60
Neutral
Williams %R
-26.78
Buy
CCI (14)
68.16
Neutral
ATR (14)
1.76
-
Ultimate Oscillator
56.64
Neutral
ROC
15.68
Buy
NewAmsterdam Pharma Company’s (NAMS) Relative Strength Index (RSI) is 56.92, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Trend Strength Indicator (ADX) is 25.60, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Commodity Channel Index (CCI) is 68.16, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Price Rate of Change (ROC) is 15.68, creating a Buy signal.
FAQ
Is NAMS a Buy, Hold, or Sell?
Based on NAMS’s technical indicators, NAMS is a Strong Buy.
What is NAMS’s RSI (14)?
NAMS’s RSI (14) is 56.92, which suggests NAMS is a Neutral.
What is NAMS’s MACD?
NAMS’s MACD is 0.78, which suggests NAMS is a Sell.
What is NAMS’s 5-day moving average?
NAMS’s 5-day moving average is 34.52, which suggests NAMS is a Buy.
What is NAMS’s 20-day moving average?
NAMS 20-day moving average is 32.64, which suggests NAMS is a Buy.
What is NAMS’s 50-day moving average?
NAMS’s 50-day moving average is 32.75, which suggests NAMS is a Buy.
What is NAMS’s 200-day moving average?
NAMS’s 200-day moving average is 31.21, which suggests NAMS is a Buy.
What is NAMS’s Williams % R (14)?
NAMS’s Williams % R (14) is -26.78, which suggests NAMS is a Buy.
What is NAMS’s CCI (14)?
NAMS’s CCI (14) is 68.16, which suggests NAMS is a Neutral.